The Hong Kong Society of Uro-oncology (HKSUO) is pleased to welcome sponsors and healthcare professionals from around the world to our 7th Annual Scientific Meeting, Uro-oncology Asia 2022.

The Annual Scientific Meeting is our keynote event. It is an important regional platform for the presentation of new understanding and approaches to disease management and treatment, and for facilitating multi-disciplinary collaboration.

Despite the extraordinary circumstances brought about by the COVID-19 pandemic, uro-oncology continues to evolve with significant progress made in our understanding of diseases and towards more personalized treatments, many of which are have already been successfully integrated into clinical use. These include exciting developments in advanced genomic testing, the maturing and more wide-spread use of immuno-oncology, and the successful integration of different treatment modalities.

We are again delighted to host a number of world class speakers from across the globe who will be sharing with us their research and experience.

I wish to thank all our members and sponsors for their continued support, without which these important meetings would not be possible.

I look forward to seeing many of you at our keynote event.